Michael J. Baum

Michael J. Baum's AcademicInfluence.com Rankings

Michael J. Baum

Computer Science

#4576

World Rank

#4828

Historical Rank

Informatics

#24

World Rank

#25

Historical Rank

computer-science Degrees

Michael J. Baum

Philosophy

#5107

World Rank

#7832

Historical Rank

Logic

#2439

World Rank

#3429

Historical Rank

philosophy Degrees

Download Badge

Computer Science
Philosophy

Michael J. Baum's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Informatics Stanford University

Why Is Michael J. Baum Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael J. Baum's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer (2005) (2258)
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial (2002) (1902)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. (2010) (1458)
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. (1994) (877)
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. (1990) (785)
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial (2014) (737)
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial (2002) (727)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. (2008) (687)
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. (2010) (666)
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial (2010) (650)
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. (2010) (518)
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. (1992) (376)
Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. (1986) (347)
The effects of surgery on tumor growth: a century of investigations. (2008) (331)
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. (1990) (326)
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. (1988) (325)
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. (2006) (279)
Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study. (2005) (261)
Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. (2001) (223)
Psychological effects of being offered choice of surgery for breast cancer (1994) (219)
Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone (1991) (192)
Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. (1989) (186)
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures (2007) (184)
Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? (2005) (184)
Late follow‐up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer (2004) (169)
TAMOXIFEN AND CONTRALATERAL BREAST CANCER (1985) (157)
The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. (2002) (142)
Intraoperative radiotherapy for breast cancer. (2004) (140)
Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. (2011) (133)
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. (2005) (131)
Hormone replacement therapy and breast cancer (1994) (128)
Dormancy and surgery‐driven escape from dormancy help explain some clinical features of breast cancer (2008) (123)
The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta. (1991) (122)
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial (2020) (119)
Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. (2001) (114)
Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer. (1998) (113)
Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study. (2006) (110)
CONTROLLED TRIAL OF TAMOXIFEN AS ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER Interim Analysis at Four Years by Nolvadex Adjuvant Trial Organisation (1983) (109)
IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER (1983) (108)
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup (2012) (104)
Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review (2013) (102)
What are the Psychological Factors Influencing Attendance, Non-Attendance and Re-Attendance at a Breast Screening Centre? (1990) (98)
Does breast cancer exist in a state of chaos? (1999) (95)
Counselling breast cancer patients: A specialist nurse service (1988) (94)
Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer. (2011) (93)
Beyond randomized controlled trials (2002) (93)
Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. (1993) (92)
A survey of breast cancer awareness and knowledge in a Western population: lots of light but little illumination. (2005) (91)
Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials. (2016) (86)
Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth? (2010) (85)
Harms from breast cancer screening outweigh benefits if death caused by treatment is included (2013) (84)
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. (2006) (83)
Postoperative seroma following mastectomy and axillary dissection (1987) (81)
New approach for recruitment into randomised controlled trials (1993) (75)
The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). (2007) (75)
Polychemotherapy for early breast cancer (1998) (75)
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial (2004) (71)
Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible? (2000) (71)
Is clinical breast examination an acceptable alternative to mammographic screening? (2000) (70)
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival (2020) (68)
Putting the risk of breast cancer in perspective (1998) (67)
Breast Cancer and Pregnancy: A Review (1993) (66)
Women need better information about routine mammography (2003) (65)
Importance of mastalgia in operable breast cancer. (1982) (64)
Significance of 'Langer's axillary arch' in axillary dissection. (1991) (63)
Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer (2009) (63)
Response of multicentric desmoid tumours to tamoxifen (1987) (62)
Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer (2015) (61)
Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial. (2011) (61)
Sociodemographic determinants of cancer treatment health literacy (2006) (59)
A new biological framework for cancer research (1996) (58)
Psychological outcomes in women with early breast cancer. (1990) (57)
An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial). (2016) (56)
Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life (2016) (56)
Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial. (2016) (55)
EVALUATION OF RADIOGRAPHY AND ISOTOPIC SCINTIGRAPHY FOR DETECTING SKELETAL METASTASES IN BREAST CANCER (1976) (54)
Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT (2016) (53)
Long term effects of tamoxifen. Biological effects of Tamoxifen Working Party. (1992) (52)
Racial disparities in breast cancer outcome (2007) (51)
Addressing the Psychological Needs of the Conservatively Treated Breast Cancer Patient: Discussion Paper (1987) (49)
The curability of breast cancer. (1976) (48)
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. (2011) (48)
Multicentricity and recurrence of breast cancer (1997) (47)
A daily diary for quality of life measurement in advanced breast cancer trials. (1993) (47)
Reticulo‐endothelial activity in humans with cancer (1970) (47)
DO WE NEED INFORMED CONSENT? (1986) (46)
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. (1983) (46)
Macrophage production by the bone marrow of tumor-bearing mice. (1972) (45)
Anastrozole, Tamoxifen, Alone or in Combination (ATAC Trial) (2003) (45)
The role of axillary dissection in operable breast cancer (1992) (43)
Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? (1995) (41)
Reflections on randomised controlled trials in surgery (1999) (41)
The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer (1999) (41)
Role of complementary and alternative medicine in the care of patients with breast cancer: report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy, December 2004. (2006) (40)
Alternative mechanisms of action of anti-oestrogens (2004) (40)
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee (2016) (40)
Primary management of carcinoma of the breast (1993) (39)
Ethics of clinical research: lessons for the future. (1989) (39)
[Breast cancer in the early stage]. (2012) (39)
Targeted intraoperative radiotherapy { Targit ) : An innovative method of treatment for early breast cancer (2005) (38)
Social class and weight as prognostic factors in early breast cancer. (1997) (38)
Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible. (2011) (37)
Decision-making in early breast cancer: guidelines and decision tools. (2002) (36)
Prevention of breast cancer (1992) (36)
Screening for breast cancer, time to think— and stop? (1995) (36)
Serum α‐1‐acid glycoprotein as an index of dissemination in breast cancer (1975) (35)
Prediction of lymph node involvement in breast cancer (1991) (35)
Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen. (1996) (35)
Abstract S4-2: Targeted intraoperative radiotherapy for early breast cancer: TARGIT-A trial- updated analysis of local recurrence and first analysis of survival (2012) (33)
The 'tru-cut' biopsy in breast cancer. (1975) (33)
Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group. (1992) (33)
Current status of aromatase inhibitors in the management of breast cancer and critique of the NCIC MA-17 trial. (2004) (33)
The role of complementary and alternative medicine in the management of early breast cancer: recommendations of the European Society of Mastology (EUSOMA). (2006) (32)
Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. (2004) (32)
Flawed inferences about screening mammography's benefit based on observational data. (2009) (32)
Tamoxifen for retroperitoneal fibrosis (1993) (31)
Breast cancer, desmoid tumours, and familial adenomatous polyposis—a unifying hypothesis (1993) (31)
Langer's axillary arch in association with sentinel lymph node. (1999) (30)
Mass breast screening: is there a hidden cost? (2003) (30)
Time to abandon TNM staging of breast cancer? (1992) (30)
Oestrogen as a Reticuloendothelial Stimulant in Patients with Cancer (1971) (30)
American and European recommendations for screening mammography in younger women: a cultural divide? (1993) (30)
Using an interactive video disk in breast cancer patient support. (1998) (29)
The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment. (2001) (29)
Treatment Outcomes and Quality of Life (1989) (27)
The Changing Face of Breast Cancer – Past, Presentand Future Perspectives (2002) (27)
Role of radiotherapy following total mastectomy in patients with early breast cancer (2004) (27)
Early stopping rules--clinical perspectives and ethical considerations. (1994) (27)
Simple mastectomy for early breast cancer and the behaviour of the untreated axillary nodes. (1977) (27)
Axillary Dissection over the Years: Where To from Here? (2001) (26)
Contrast‐enhanced colour Doppler ultrasonography in suspected breast cancer recurrence (1999) (25)
THE MANAGEMENT OF ADVANCED BREAST CANCER (1970) (25)
Can we prevent breast cancer? (1991) (25)
Does surgery disseminate or accelerate cancer? (1996) (25)
Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen. (1993) (25)
Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen. (1996) (25)
Cancer Clinical Trials (1988) (24)
Prophylactic mastectomy for genetic predisposition to breast cancer: the proband's story. (1996) (24)
Antitumour effect of corynebacterium parvum. Possible mode of action. (1976) (24)
The Hamburg statement: the partnership driving the European agenda on breast cancer. (2004) (23)
Breast cancer in the elderly: Surgery improves survival. The results of a cancer research campaign trial (2001) (23)
The current status of aromatase inhibitors in the management of breast cancer. (2003) (23)
Psychological Welfare of Patients with Breast Cancer (1989) (23)
Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer (1993) (23)
Randomised Controlled Clinical Trial: Targeted Intraoperative radiotherapy (Targit)- comparing targeted intra-operative radiotherapy with conventional post-operative radiotherapy after breast conserving surgery for early stage breast cancer. (1999) (23)
Adjuvant Zoladex in premenopausal patients with early breast cancer: results from the ZIPP trial. (2001) (22)
Organization of Clinical Trial on National Scale: Management of Early Cancer of the Breast (1972) (22)
A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial. (2009) (22)
Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. (2002) (22)
Mondor's disease as a presenting symptom of breast cancer (1987) (21)
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer (2021) (21)
Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? (1998) (21)
Has tamoxifen had its day? (2002) (19)
RESULTS OF THE CANCER-RESEARCH CAMPAIGN ADJUVANT TRIAL FOR PERIOPERATIVE CYCLOPHOSPHAMIDE AND LONG-TERM TAMOXIFEN IN EARLY BREAST-CANCER REPORTED AT THE 10TH YEAR OF FOLLOW-UP (1992) (19)
Clinical trials -- a brave new partnership: a response to Mrs. Thornton. (1994) (19)
Cosmetic outcome after targeted intraoperative radiotherapy (targit) for early breast caner. (2003) (19)
A novel binding site for a synthetic progestagen in breast cancer cells. (1989) (19)
SAFETY OF TAMOXIFEN (1978) (19)
Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now? (2005) (19)
Radiotherapy for breast cancer, the TARGIT-A trial – Authors' reply (2014) (18)
Hypotonic duodenography in the diagnosis of carcinoma of the pancreas and its further use when combined with percutaneous cholangiography and pancreatic scintiscanning. (1968) (18)
The operative management of subclinical breast cancer. (1977) (18)
The role of radiotherapy following total mastectomy for patients with early breast cancer (1985) (18)
Breast cancer: A revolutionary concept (1995) (18)
Regression of axillary lymph‐nodes in cancer of the breast (1972) (17)
Management of desmoid tumours including a case report of toremifene. (1994) (17)
Chest radiography in the management of breast cancer. (1992) (17)
10-year analysis of the ATAC trial: wrong conclusion? – Authors' reply (2011) (17)
Contribution of randomised controlled trials to understanding and management of early breast cancer (1999) (16)
Breast cancer screening comes full circle. (2004) (16)
Differences in oestrogen receptors in malignant and normal breast tissue as identified by the binding of a new synthetic progestogen. (1986) (16)
Breast cancer 2000 BC to 2000 AD--time for a paradigm shift? (1993) (16)
FAMILIAL MALE BREAST CANCER (1976) (16)
Still awaiting screening facts (2010) (16)
Clinical and biological implications of the Milan breast conservation trials. (1998) (15)
Tissue screening after breast reduction (2009) (15)
Primary medical (neoadjuvant) chemotherapy for operable breast cancer: Building on early promise (1992) (15)
The ethics of randomized controlled trials. (1995) (15)
Promising development from translational or perhaps anti-translational research in breast cancer (2012) (15)
Targeted Intra‐operative Radiotherapy—TARGIT for Early Breast Cancer (2008) (15)
Randomised trials are not unethical (1999) (15)
Commentary: false premises, false promises and false positives--the case against mammographic screening for breast cancer. (2004) (15)
Subpectoral breast reconstruction using the biodimensional system. (1997) (14)
An approach to randomization into surgical clinical trials (2017) (14)
A clinical trial of mithramycin in the treatment of advanced malignant disease. (1968) (14)
Delay in presentation of women with breast disease. (1976) (14)
Modern concepts of the natural history of breast cancer: a guide to the design and publication of trials of the treatment of breast cancer. (2013) (14)
What are the needs of patients diagnosed with cancer? (2004) (13)
Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials. (1984) (13)
Large differences in survival are not explained (1996) (13)
Targeted radiotherapy for early breast cancer (2018) (13)
Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment (2021) (13)
Breast cancer screening peril Negative consequences of the breast screening programme (2009) (12)
Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
Commentary on "Accelerated partial breast irradiation consensus statement: Update of an ASTRO Evidence-Based Consensus Statement". (2017) (12)
Targeted intraoperative radiotherapy (TARGIT) for breast cancer: An international trial (2002) (12)
The Lower Non-Breast Cancer Mortality With TARGIT in the TARGIT-A Trial Could Be a Systemic Effect of TARGIT on Tumor Microenvironment (2013) (12)
Role of TGFβ in the anti-estrogen response/resistance of human breast cancer (1996) (12)
P99 Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer (1998) (12)
Orthotopic transplantation of the pig heart (1970) (12)
Current and future roles of adjuvant endocrine therapy in the management of early carcinoma of the breast. (1996) (12)
‘Should a mammographic screening programme carry the warning: Screening can damage your health!’? (1999) (12)
Breast cancer in women with palpable breast cysts. (1999) (12)
Screening for breast cancer with mammography (2001) (12)
Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells. (1996) (12)
Management of premenopausal women with early breast cancer. Is there a role for Goserelin (2001) (12)
Will breast self-examination save lives? (1982) (12)
Breast-conserving surgery with intra-operative radiotherapy: the right approach for the 21st century? (2006) (12)
The breast screening controversy. (1996) (11)
Ethics of clinical trials: the ‘forbidden fruit’ phenomena (1996) (11)
Who truly represents the needs of the consumer diagnosed with breast cancer? Who are these patients' advocates? How are they informed? What, if any, are their secret agendas? (1997) (11)
Measurement of quality of life in advanced breast cancer. (1990) (11)
Hormone Replacement Therapy in Women with Previous Breast Cancer (1998) (11)
Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer (1984) (11)
Prospects for the chemoprevention of breast cancer (1991) (11)
The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers. (1986) (11)
Mass screening for cancer of the breast. (1968) (11)
Intraoperative radiotherapy: the debate continues. (2004) (11)
Is there a role for perioperative adjuvant therapy in the treatment of early breast cancer? (1988) (11)
Carcinoma of the Head of the Pancreas Developing in a Young Woman with a Choledochal Cyst (1975) (11)
The future of breast cancer research in danger. (2002) (10)
Diseases of the breast (2000) (10)
Variations in gastric cancer mortality in South Wales. (1979) (10)
Prediction of human spleen size by computer analysis of splenic scintigrams. (1976) (10)
Prospects for the chemoprevention of breast cancer. (1991) (10)
Tamoxifen induces the expression of cytoplasmic c-erbB2 immunoreactivity in oestrogen-receptor positive breast carcinomas in-vivo (1993) (10)
Mastectomy or conservation: the patient's choice. (1988) (10)
Management of early carcinoma of the breast. (1972) (10)
The hypronosticon test in breast cancer. (1975) (10)
Benign breast disease: The cost of the service and the cost to the patient (1989) (10)
Survival and reduction in mortality from breast cancer (2000) (10)
An exploration of relapse data by hazard rate as a means of developing biological insights into the natural history and treatment of breast cancer: Data from the ’Arimidex’, Tamoxifen, Alone or in Combination (ATAC) trial and the Milan Institute database (2005) (10)
Radiation-induced sarcoma of the retained breast after conservative surgery and radiotherapy for early breast cancer. (1993) (9)
Cancer clinical trials : a critical appraisal (1988) (9)
Shared decision-making using an interactive video disk system for women with early breast cancer (1998) (9)
DEATH TAKES A HOLIDAY (1988) (9)
NICE Guidelines: management of colorectal cancer metastases (2020) (9)
0-48. A randomised pilot study of HRT in breast cancer patients: the combined effects of tamoxifen and HRT on the endometrium (1997) (9)
Should Routine Screening by Mammography be Replaced by a More Selective Service of Risk Assessment/Risk Management? (2010) (9)
Functional Maps of Metastases from Breast Cancers: Proof of the Principle that Multidimensional Scaling Can Summarize Disease Progression (2004) (8)
Letter: Methyl-cholanthrene-induced sarcomata in mice after immunisation with Corynebacterium parvum plus syngeneic subcellular membrane fractions. (1974) (8)
'Early' breast cancer, bone scanning, and the urinary excretion of hydroxyproline. (1973) (8)
Partial breast irradiation and the GEC-ESTRO trial (2016) (8)
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. (1987) (8)
Why Does the Weeping Willow Weep? Reconceptualizing Oncogenesis in Breast Cancer. (2015) (8)
Intraoperative radiotherapy for breast cancer: powerful evidence to change practice (2021) (8)
Does the act of surgery provoke activation of "latent" metastases in early breast cancer? (2004) (8)
Patients' perception of risk and breast cancer awareness. (1997) (8)
Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates? (2012) (8)
Screening mammography re-evaluated (2000) (8)
SCREENING FOR BREAST CANCER (1984) (8)
INFORMED CONSENT AND CONTROLLED TRIALS (1988) (8)
Management of premenopausal women with early-stage breast cancer: is there a role for ovarian suppression? (2002) (8)
Lymphoedema--prevention rather than cure. (1991) (8)
Is it time for a paradigm shift in the training of breast surgeons as a sub-speciality?! (2003) (8)
The role of endocrine therapy in primary breast cancer. (1990) (7)
TRIALS OF ADJUVANT CHEMOTHERAPY IN BREAST CANCER (1979) (7)
Pure antioestrogens in breast cancer - experimental and clinical observations (1994) (7)
The BRCA paradox in breast and ovarian cancer. (1998) (7)
Adjuvant use of anastrozole in breast cancer. (2004) (7)
Quality of life during treatment for cancer. (1992) (7)
Magnetic-resonance imaging and breast cancer multicentricity (1998) (7)
Abstract P5-13-03: The Influences of Co-Morbidities and Age on Risk of Death without Recurrence: A Retrospective Analysis of the ATAC Trial (2010) (7)
Letter: Predictive value of hydroxyproline: creatinine ratio in advanced breast cancer. (1975) (7)
Role of TGF beta in the anti-estrogen response/resistance of human breast cancer. (1996) (7)
Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems (1992) (7)
The Natural History of Breast Cancer (2017) (7)
Proceedings: macrophage phagocytic activity in patients with breast cancer. (1973) (7)
Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. (2007) (6)
re: Reflections on screening mammography and the early detection of breast cancer. (2014) (6)
Prophylactic radiotherapy following surgery for early breast cancer - is the benefit mainly to patients with involved margins? Results from a Cancer Research Campaign Trial (2001) (6)
The price of autonomy (1999) (6)
‘Catch it early, save a life and save a breast’: this misleading mantra of mammography (2015) (6)
Loco-regional therapy and breast cancer survival: searching for a link. (2013) (6)
Targeted Intraoperative Radiotherapy for Early Breast Cancer-Reply. (2020) (6)
Transforming growth factor beta related to extent of tumor angiogenesis but not apoptosis or proliferation in breast carcinoma (1999) (6)
The role of adjuvant endocrine therapy in primary breast cancer. (1989) (6)
A Roundtable Discussion of Aromatase Inhibitors as Therapy for Breast Cancer (2003) (6)
A family history of breast Ca. (1997) (6)
Serum alpha-1-acid glycoprotein as an index of dissemination in breast cancer. (1975) (6)
Effect of surgery on monocyte function. (1983) (6)
0-70. The addition of surgery to tamoxifen as primary treatment of early breast cancer in women over 70, a multicentre trial (1997) (6)
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems (2022) (6)
Women's advocacy groups and research in breast cancer (2001) (6)
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer (1985) (6)
Intra-operative breast radiation: the targeted intra-operative radiotherapy (Targit) trial (2003) (6)
Breast cancer screening for younger women is not an efficient use of resources (1997) (6)
Epidemiology Versus Scare Mongering: The Case for the Humane Interpretation of Statistics and Breast Cancer (2000) (6)
Fast Facts Breast Cancer 3rd Edition (2005) (6)
A New Approach to Treating Breast Cancer Combining Tumor Removal and Intraoperative Radiotherapy: Is it Viable? (2010) (6)
Spleen size in women with breast cancer. (1979) (6)
Endometrial cancer during tamoxifen treatment (1994) (6)
La Fornarina: breast cancer or not? (2003) (6)
Efficacy of targeted intraoperative radiotherapy (Targit) boost after breast-conserving surgery: Updated results (2008) (6)
Confirmed dissent and informed consent. (1993) (6)
Screening and mortality from cervical cancer (1999) (6)
Breast cancer--a challenge to the contemporary paradigm. (1996) (6)
Leucoerythroblastosis in breast cancer. (1975) (6)
Targeted intra-operative radiotherapy (TARGIT) for breast cancer: A randomised trial (2001) (6)
The Skinner Lecture: a cost-benefit analysis of postoperative radiotherapy in the treatment of early breast cancer. (1991) (6)
Targeted intraoperative radiotherapy (TARGIT) as a boost yields very low recurrence rates. (2005) (6)
The role of local treatment for primary carcinoma of the breast. (1978) (6)
The clinical behaviour of untreated axillary nodes following simple mastectomy for early carcinoma of the breast. (1980) (5)
Targeted intraoperative radiotherapy for breast cancer - a randomised trial (2001) (5)
Letters to the EditorEMERGENCY TREATMENT OF HYPERCALCÆMIA (1967) (5)
Pre-implantation genetic diagnosis (PGD): the spectre of eugenics or a "no brainer". (2006) (5)
Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations [4] (multiple letters) (1997) (5)
F170 A randomised controlled trial of hormone replacement therapy in breast cancer patients — A feasibility study (1996) (5)
BREAST CANCER IN A SCHOOLGIRL (1976) (5)
Management of early-onset breast cancer and BRCA1 or BRCA2 status (2002) (5)
0-38. Identification of clinical factors predicting outcome following primary chemotherapy for operable breast cancer (1997) (5)
Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? (2013) (5)
Atlas of Breast Cancer (1994) (5)
0-74. A randomised, double blind, parallel-group trial to evaluate the effect of ‘Arimidex’ (anastrozole) on the pharmacokinetics of tamoxifen in postmenopausal breast cancer patients (1997) (5)
1. Prognostic and predictive factors for early breast cancer (1996) (5)
How does tamoxifen interact with chemotherapy? (1991) (5)
Effect of screening programme on mortality from breast cancer. Investment in treatment would be more cost effective. (2000) (5)
Letrozole or tamoxifen in early breast cancer. (2006) (5)
Does preoperative MRI influence the extent of surgical resection in conservative breast cancer surgery (1999) (5)
Safety and efficacy of targeted intraoperative radiotherapy (TARGIT) for early breast cancer: First report of a randomized controlled trial at 10-years maximum follow-up. (2010) (5)
Ventriculo-peritoneal shunt and breast carcinoma. (2001) (5)
Omitting Whole Breast Radiation Therapy did not Increase Axillary Recurrence in the TARGIT-A Trial (2013) (5)
Tumour histology and spleen size in women with breast cancer. (1980) (5)
Breast cancer and the black swan (2020) (4)
Medullary Carcinoma of Breast (1970) (4)
Antiviral effect of tamoxifen (1993) (4)
Women need better information on routine mammography (2003) (4)
Proceedings: Spleen size in patients with breast cancer. (1975) (4)
Tamoxifen to prevent breast cancer (1991) (4)
Acute and modified rejection of heterotopic canine cardiac allotransplants studied by serial needle biopsy (1971) (4)
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial (2016) (4)
A surgical perspective of breast MRI (2002) (4)
Bristol Cancer Help Centre (1990) (4)
Publishing surgery (2000) (4)
The control of acute menopausal symptoms in breast cancer survivors. (2000) (4)
Rethink on screening for breast cancer (1997) (4)
FEWER NON-BREAST CANCER DEATHS IN TARGIT-A TRIAL: SYSTEMIC BENEFIT OF TARGIT OR LACK OF EBRT TOXICITY (2013) (4)
Biological considerations in the treatment of breast cancer: the "fall out" from clinical trials. (1975) (4)
CURRENT AND FUTURE MANAGEMENT OF "EARLY" BREAST CANCER: ATTITUDE SURVEY AMONGST PARTICIPANTS IN CANCER RESEARCH CAMPAIGN TRIAL (1980) (4)
Current thinking on the management of primary carcinoma of the breast. (1983) (4)
Cosmesis and breast-related quality of life outcomes following intra-operative radiotherapy for early breast cancer - a sub-study of the TARGIT - a trial (2016) (4)
Further analysis as requested by the National Institute for Health and Care Excellence (2016) (4)
Should lymphadenectomy be discarded? I. Immunological considerations. (1973) (4)
The extent and necessity of axillary dissection in breast cancer surgery (1995) (4)
Clinical trials in cancer: what makes for a successful study? (2000) (4)
Targeted Intraoperative Radiotherapy — TARGIT for Early Breast Cancer Can We Spare the Patient Daily Journeys to the Radiotherapist ? (2008) (4)
Quality of life assessments may help some patients (1998) (4)
NSAID Analgesic Ketorolac Used Perioperatively May Suppress Early Breast Cancer Relapse: Something for Nothing in Breast Cancer ? (2011) (3)
Adjuvant treatment with tamoxifen (1996) (3)
Biological considerations in the treatment of early carcinoma of the breast and their role in the selection of therapy. (1980) (3)
Sociodemographic determinants of cancer treatment health literacy. Authors' reply (2006) (3)
Effect of abnormal screening mammogram on quality of life (Br J Surg DOI: 10.1002/bjs.7371) (2011) (3)
Macrophage production in response to the growth of an experimental tumour. (1972) (3)
Tamoxifen alone is not adequate treatment for most elderly patients with operable breast cancer (1992) (3)
Trials in breast cancer. (1979) (3)
Breast screening. Informed consent for mammographic screening. (1999) (3)
Informed consent may increase non-attendance rate (1995) (3)
Tamoxifen and the breast (1998) (3)
Autocrine TGFβ Synthesis by T47D Breast Cancer Cells in Response to a Novel Synthetic Progestin (1990) (3)
Terminology for carcinoma-in-situ of the breast (1996) (3)
Homoeopathy waives the rules (2010) (3)
Classic Papers in Breast Disease (2001) (3)
BREAST CANCER IN WOMEN WITH PALPABLE BREAST CYSTS. AUTHORS' REPLY (1999) (3)
DELAYED ASSESSMENT OF MAMMOGRAPHIC ABNORMALITIES (1988) (3)
Ramifications of screening for breast cancer: Consent for screening (2006) (3)
Mithramycin Treatment of Hypercalcaemia and Renal Failure in a Patient with Paratesticular Embryonic Sarcoma (1971) (3)
Breast cancer and pregnancy. (1994) (3)
Assessment of response to neoadjuvant chemotherapy in advanced breast cancer using MRI (1997) (3)
Undesirable Gynaecological and Operative Interventions during Treatment of Breast Cancer with Anastrozole and Tamoxifen (2010) (3)
A very low recurrence rate is achieved by a targeted intraoperative radiotherapy (TARGIT) boost after breast conserving surgery for cancer (2006) (3)
False alarms of breast cancer (1990) (3)
EMERGENCY TREATMENT OF HYPERCALCÆMIA (1967) (3)
Informed consent (1998) (3)
Conventional Adjuvant Hormonal Therapy (2001) (3)
Targeted intraoperative radiotherapy (Targit) boost after breast conserving surgery results in a remarkably low recurrence rate in a standard risk population: 5 year results (2009) (3)
Psion of the times (1997) (2)
Testing for cancer. (1978) (2)
Simple mastectomy for carcinoma of the breast. (1978) (2)
Hormone replacement therapy. Should be used selectively. (1994) (2)
Proceedings: Studies on breast pain. (1974) (2)
Depression of delayed hypersensitivity and abnormal bone scans in early cancer of the breast. (1972) (2)
Primary cancer of the breast. (1970) (2)
I.1 Tamoxifen and the breast (1998) (2)
Local Recurrence and Survival for the German Centers in the TARGIT-A (TARGeted Intraoperative Radiation Therapy - Alone) Trial (2013) (2)
RETROVIRUSES IN MONOCYTES FROM PATIENTS WITH BREAST CANCER (1988) (2)
Setting up a breast cancer family history clinic. (1999) (2)
Detection of breast cancer multicentricity with MRI (1998) (2)
P3-13-07: The TARGIT-A Trial Update Confirms No Increase in Local Recurrence. (2011) (2)
Transforming growth factor beta isoforms in breast cancer. (1994) (2)
Pain scores in haemorrhoidectomy (1988) (2)
Quack cancer cures or scientific remedies? (1983) (2)
Can surgery provoke the outgrowth of latent breast cancer? A unifying hypothesis (2007) (2)
Intra-operative radiotherapy for breast cancer in patients where external beam radiation was not possible - results after 3 years of follow-up (2009) (2)
Cancer and its treatments, and the reticulo-endothelial system in man. (1968) (2)
Disappointments of pancreatic scintiscanning. (1968) (2)
Treatment of early breast cancer: the organization of a 'national trial'. (1971) (2)
ER, PgR, c-erbB2 and EGFr in patients randomised to adjuvant tamoxifen or no treatment: associations with treatment benefit (1999) (2)
Informed consent in medical research. The whole population must be mobilised in the war against cancer. (1997) (2)
Breast cancer, desmoid tumours and familial adenomatous polyposis coli — A unifying hypothesis (1994) (2)
MULTIMODAL THERAPY FOR STAGE-II BREAST CANCER (1977) (2)
In Regard to Hepel and Wazer. (2015) (2)
A Long Breast Cancer Remission without Standard Therapy (2015) (2)
NHS breast screening programme. Money may be better spent on symptomatic women. (1999) (2)
Percutaneous minimally invasive stereotactic primary radiotherapy: A novel approach for breast cancer in elderly women (2001) (2)
Targeted intraoperative radiotherapy (Targit): A novel approach to local treatment of breast cancer (2000) (2)
Breast cancer patients treated with intra-operative radiotherapy alone when conventional external beam radiation therapy was not possible (2008) (2)
Breast Beating; A personal Odyssey in the quest for the understanding of breast cancer the meaning of life and other easy questions. (2010) (2)
BREAST CANCER CONTROVERSIES (1985) (2)
Does screening really reduce mortality (1999) (2)
Breast cancer survival and the use of HRT. (2005) (2)
Adjuvant Radiotherapy in Breast Cancer: Consideration of Cost-Benefits in Relation to the CRC (King's/Cambridge) Trial (1989) (2)
Primary medical chemotherapy with continuous infusional 5-fu (F), epirubicin (E) and cisplatin (P) for large operable breast cancer: a very active new regimen (1993) (1)
Preoperative MRI does not influence the amount of breast tissue excised in conservative cancer surgery (1998) (1)
Changing philosophical perspectives in breast (2001) (1)
'Cure' from breast cancer amongst two populations of women followed for twenty-three years after diagnosis (poster presentation) (2008) (1)
Monoarthritis of the ankle: an unusual presentation of metastatic breast carcinoma. (1994) (1)
Women need better information on routine mammography - Reply (2003) (1)
TAMOXIFEN THERAPY, OESTROGEN RECEPTOR STATUS, AND POSTMENOPAUSAL BREAST CANCER (1985) (1)
Reactionary approach inhibits progress (1994) (1)
Achieving a biological profile of the breast cancer patient. (1982) (1)
Is there a role for perioperative adjuvant cytotoxic therapy in the treatment of early breast cancer? (1989) (1)
OC-0472: Whole breast radiotherapy does not affect growth of cancer foci in other quadrants: results from the TARGIT Atrial (2015) (1)
Sequential power calculations in a recruitment phase of a multicentre trial – the experience of the ‘Arimidex (anastrozole), tamoxifen alone or in combination’ (ATAC) study. (2002) (1)
Clinical practice to address tamoxifen nonadherence (2020) (1)
Comment to Jatoi et al. report (2005) (1)
Proceedings: The relationship between spleen size, clinical staging and histological features in breast cancer. (1975) (1)
Endometrial cancer during tamoxifen treatment. Cancer Research Campaign Breast Cancer Trials Group. (1994) (1)
The Cancer Research Campaign trials of adjuvant therapy for early breast cancer. (1989) (1)
OMITTING WHOLE BREAST RADIOTHERAPY DOES NOT INCREASE AXILLARY RECURRENCE - DATA FROM TARGIT-A TRIAL (2013) (1)
Diagnosis and management of early stage breast cancer. (1995) (1)
Importance of Long-Term Follow-Up of Women Receiving Adjuvant Therapy for Breast Cancer in the Community Reply (2011) (1)
TARGIT (targeted intra-operative radiotherapy for early stage breast cancer): Results from the TARGIT a randomized controlled trial (2010) (1)
WHO NEEDS STEROID RECEPTOR ASSAYS? (1989) (1)
How Much of the Effect of Chemotherapy Is Due to Hormonal Manipulation (1993) (1)
MRI in the detection of breast cancer multicentricity (1998) (1)
Primary cancer of the breast. (1970) (1)
CONSENT TO RANDOMISED TREATMENT (1982) (1)
Breast cancer patients treated with intra-operative radiotherapy [IORT] alone when conventional external beam radiation therapy [EBRT] was not possible (2008) (1)
Radiation safety for the sentinel lymph node (SLN) technique in breast cancer (1999) (1)
Radiation safety issues for sentinel node biopsy in breast cancer (1999) (1)
Functional maps: a novel way of visualizing patterns of recurrence of breast cancer (2003) (1)
Surgery and radiotherapy in breast cancer. (1974) (1)
Questions about anastrozole for early breast cancer (2002) (1)
Rapid diagnosis breast clinic as a cost effective means of triage for symptomatic breast patients (1998) (1)
Screening of inherited breast cancer with DNA markers (1993) (1)
TARGIT (Targeted intra-operative radiotherapy for early stage breast cancer): Early results from the multi-centre randomized controlled trial (2010) (1)
Molecular staging of cancer (1997) (1)
A survey of the opinions on ‘informed consent’ of women attending a breast unit (1993) (1)
The Low Randomisation Rate in a Trial of Lung Metastasectomy Was More Often Due to Failure of Clinical Equipoise Rather Than Patients' Unwillingness to Be Randomised (2020) (1)
Radiosurgery: A novel method of treatment of early breast cancer (1998) (1)
Long-term benefits of 5 years of tamoxifen: 10 year follow up of a large randomised trial in women aged at least 50 years with early breast cancer (2011) (1)
0116 Intra-operative radiotherapy for breast cancer in patients where external beam radiation was not possible - results after 3 years of follow-up (2009) (1)
Local recurrence of breast cancer: new concepts about its biology and clinical relevance (1997) (1)
Sex steroids and malignancies. (1997) (1)
Results from the NATO and CRC Trials of Adjuvant Tamoxifen Therapy (1995) (1)
Publishing surgery [letter] (2000) (1)
Medical ethics (1994) (1)
Informed Choice and Breast Cancer Screening (2006) (1)
103. Duration of adjuvant tamoxifen therapy: preliminary results from the CRC trial (1995) (1)
Targeted intraoperative radiotherapy: An innovative method of treatment for early breast cancer (2001) (1)
Breast cancer trials--a new initiative. (1980) (1)
Transforming growth factor ,Bisoforms inbreast cancer (1994) (1)
What is newsworthy? Frenzy to feed the media can be bad for patients. (2002) (1)
The use of liposomes in the diagnosis and treatment of malignant disease. (1987) (1)
Prevention of breast cancer. (1992) (1)
Surgery for early breast cancer improves survival in the elderly: result of a randomized trial of tamoxifen alone versus surgery plus tamoxifen (2001) (1)
Adjuvant chemotherapy for common solid tumors. (1983) (1)
Involvement of the consumer voice (2006) (1)
Book Review: ABC of Breast Diseases (1995) (1)
The TNM staging of breast cancer should be abandoned (1992) (1)
Current status of aromatase inhibitors (2002) (1)
The endocrine management of postmenopausal women with early breast cancer (2004) (1)
Screening and mortality from cervical cancer (multiple letters) [4] (1999) (1)
Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations. (1997) (1)
Value of mammography for women aged 40-49 (1995) (1)
Future treatment of early carcinoma of the breast (1994) (1)
24. Synthesis and secretion of TGFb isoforms by breast tumour fibroblasts in vitro and modulation by tamoxifen (1995) (1)
Multicentricity of breast cancer: new findings and their clinical and biological implications (1997) (1)
Adjuvant goserelin in premenopausal patients with early breast cancer: results from the ‘Zoladex’ in premenopausal patients (ZIPP) trial (2006) (1)
Breast-conserving Surgery with Intraoperative Radiotherapy : The Right Approach for the 21 st Century ? (2006) (1)
Updated results of local control and first analysis of survival from the randomised trial of risk-adapted TARGeted Intraoperative radioTherapy (TARGIT-A) for early breast cancer (2013) (1)
Ramifications of screening for breast cancer (2006) (1)
Can we prevent breast cancer? [editorial] (1991) (1)
Abstract P2-01-01: Early relapses in breast cancer can be prevented by a perioperative NSAID, which would be a solution to a 2000 year old problem (2019) (0)
PERSPECTIVE – Baum 836 Examples of relative risk in women ’ s health Adjuvant chemotherapy after surgery for breast cancer (2006) (0)
Is breast MRI superior to clinical examination in the assessment of response to primary medical therapy (2000) (0)
The targeted intraoperative radiotherapy (TARGIT) trial for breast cancer: a review after the first 10 years of clinical application (2010) (0)
Cancer and Reproductive Health: Pregnancy and breast cancer (2008) (0)
Ethics of clinical research: Authors' reply (1989) (0)
Abstract PD06-01: A Single Treatment with Targeted Intraoperative Radiotherapy (TARGIT) Is Similar to Several Weeks of External Beam Radiotherapy (EBRT) with Respect to Efficacy and Safety, and Has Obvious Advantages to the Patient and the Economy (2010) (0)
Mammographic screening for breast cancer. (2003) (0)
Updated results of early trials of targeted intraoperative radiotherapy (TARGIT) for breast cancer (2003) (0)
List of presentations (2016) (0)
Single dose radiotherapy during surgery for breast cancer patients where external beam radiation was not feasible - results after 3 years of follow-up (2009) (0)
TREATMENT OF EARLY BREAST CANCER (1978) (0)
248 Single dose intra-operative radiotherapy for breast cancer patients where external beam radiation was not feasible – results after 3 years of follow-up (2010) (0)
Imprint cytology and the sentinel node in breast carcinoma (2000) (0)
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually : Gail MH, Brinton LA, Byar DP, et al. (2004) (0)
Breast disease: refer or a reassure? (1998) (0)
Cancer care decision support for WBC growth-factors (GF): Geographic differences in utilization and provider malleability. (2016) (0)
Technical aspects of lymphoscintigraphy. (1999) (0)
Informed consent for mammographic screening (Letter) (1999) (0)
Adjuvant Endocrine Therapy: Its Role in Primary Breast Cancer (1991) (0)
Society for Endocrinology comments on the assessment report for the National Institute for Health and Clinical Excellence Appraisal of Hormonal therapies for the adjuvant treatment of early breast cancer (2006) (0)
A pain free injection system for administration of radionuclide tracer. (1999) (0)
INSIGHTS INTO THE NATURAL HISTORY OF SUBCLINICAL BREAST CANCER: A BIOLOGICAL FALL OUT FROM THE TARGIT-A TRIAL (2012) (0)
0-86. Local recurrence of breast cancer: new concepts about its biology and clinical relevance (1997) (0)
International Steering Committee and Data Monitoring Committee (2016) (0)
O-50 TARGIT (targeted intra-operative radiotherapy for early stage breast cancer): Results from the TARGIT a randomized controlled trial (2010) (0)
Cancer of the Breast: Forward Look in the 1970s (1974) (0)
Culture bias in the tamoxifen trials & tribulations (1998) (0)
Letter: Familial male breast cancer. (1976) (0)
Contrast enhanced colour Doppler ultrasound in the differentiation of scar from recurrence in breast cancer. (1999) (0)
Primary medical (neoadjuvant) chemotherapy with continuous infusional 5-FU (F), epirubicin (E) and cisplatin (P) for large operable breast cancer: A very active new regimen (1993) (0)
Secretion of TGFβ isoforms by breast tumour fibroblasts in vitro (1993) (0)
Towards more “informed” consent in clinical trials: An information booklet for patients and physicians in the UK (1991) (0)
Commentary Does the act of surgery provoke activation of "latent" metastases in early breast cancer? (2004) (0)
Breast cancer trials—a new initiative (1980) (0)
re: Radial scar and carcinoma of the breast - microscopic findings in 32 cases. 1999; 8 : 339-347 (2000) (0)
Current management questionnaires and protocol design (1984) (0)
Sentinel lymph node biopsy in breast cancer: specific requirements for radiation safety. (1999) (0)
Cost–utility analysis of external beam radiotherapy compared with targeted intraoperative radiotherapy in breast cancer (2016) (0)
A randomised, double blind, parallel- group trial to evaluate the effect of the aromatase inhibitor anastrozole on the pharmacokinetics of tamoxifen (TAM) in postmenopausal breast cancer patients (1997) (0)
Breast cancer risk and hormone replacement therapy (1999) (0)
Prognosis and prediction for early breast cancer. (1993) (0)
Combination ormildsingle agentchemotherapy foradvanced breast cancer? CMF vsepirubicin measuring Quality ofLife (1993) (0)
TARGIT: an international trial of intraoperative versus external beam radiotherapy (2008) (0)
TARGIT-A trial: Updated results for local recurrence and survival for the German centers. (2013) (0)
Design of pathology request forms. (1993) (0)
Letter: Pituitary ablation for leucoerythroblastosis in carcinoma of breast. (1973) (0)
Investigation of a novel pure antioestrogen in women with primary breast cancer (1993) (0)
Whole breast radiotherapy does not affect growth of cancer foci in other quadrants: results from the TARGIT A trial (2015) (0)
Updates from the TARGIT A trial for the German centers: Local recurrence and survival (2014) (0)
0-106. Duration of tamoxifen therapy in women with early, operable breast cancer over the age of fifty (1997) (0)
A lifetime in breast cancer research. (2007) (0)
Radical scar and carcinoma of the breast - Microscopic findings in 32 cases (Letter) (2000) (0)
TRIALS OF ADJUVANT THERAPY IN BREAST CANCER (1979) (0)
Early Cancer" vs. "Dormant Cancer" and the potential hazards of the rush to surgery(e-Letter) (1999) (0)
0-68. Fraction of normal remaining life: a new method of defining cure in early breast cancer (1997) (0)
Trends in primary breast cancer management. Where are we going? (1990) (0)
The ethics of clinical trials. (1995) (0)
National Comprehensive Cancer Network petitions: Submissions and outcomes. (2016) (0)
The ATAC Trial - a unique collaboration between industry and academia: implications for the design of future breast cancer trials (1999) (0)
Breast cancer in women with palpable breast cysts (Letter) (1999) (0)
Breast cancer--mysteries of the axillary pyramid. (1998) (0)
Breast cancer (1985) (0)
Campaign strategy and tactics for clinical trials in surgical oncology. (1998) (0)
The importance of (A) rapid data processing and (B) randomization in phase II trials of cytotoxics in oncology illustrated by the trials of an analogue of cisplatin (1984) (0)
Immunotherapy in treatment of breast cancer. (1974) (0)
Magnetic-resonance imaging and breast cancer multicentricity (multiple letters) [5] (1998) (0)
Indices of acute rejection after cardiac transplantation. (1971) (0)
Molecular diagnosis of cancer (1997) (0)
MAGNETIC-RESONANCE IMAGING AND BREAST CANCER MULTICENTRICITY. AUTHORS' REPLY (1998) (0)
Book review: Surgical Ethics (2000) (0)
Molecular staging of cancer (multiple letters) [17] (1997) (0)
The radium treatment of carcinoma of the breast : Keynes J (2004) (0)
323 Risk assessment and risk management in familial predisposition to breast cancer (1995) (0)
Fraction of normal remaining life: a new method of defining cure in early breast cancer (1997) (0)
Communication of breast cancer prognosis: Women wish to know their chance of cure (1998) (0)
Method of data collection for patients treated with TARGIT using the INTRABEAM device as per National Institute for Health and Care Excellence draft guidance (2016) (0)
Radiosurgery: An innovative method of local treatment for breast cancer (1999) (0)
Geographic practice patterns in the selection of adjuvant dose dense (DD) chemotherapy among stage 1 breast cancer (BC) patients. (2016) (0)
Cancer research campaign clinical trials centre—its contribution to improved clinical trial methodology (1984) (0)
Genetic predisposition to breast cancer: the ethical dilemma (1997) (0)
The role of post operative radiotherapy after breast conserving surgery in the presence of systemic therapy: A CRC multicentre trial. (1999) (0)
Endocrine Aspects of Adjuvant Treatment of Breast Cancer (1993) (0)
Importance of non-linear mathematical modelling in hypothesis generation in cancer with special reference to breast cancer (1997) (0)
Development of methodology to aid participation in colorectal cancer marker study (1984) (0)
Differentiation of breast cancer recurrence from scar tissue by contrast-enhanced Doppler ultrasound; implication for breast biopsy (1999) (0)
Radiation safety considerations in sentinel node localization. (1999) (0)
P2.16-02 Randomising Patients into Trials of Thoracic Cancer Surgery: An Analysis of Patient and Cancer Team Behaviour in Practice (2019) (0)
The Enigma of Breast Cancer Metastasis (1999) (0)
286 POSTER Use of intra-operative radiotherapy [IORT] alone in breast cancer patients when conventional external beam radiation therapy [EBRT] was not possible (2006) (0)
BREAST CANCER SCREENING REVIEW An appeal to Mike Richards (2011) (0)
Role of impact cytology in sentinel node biopsy for breast cancer (1999) (0)
Mammographic screening: a common cause of statistics! (2006) (0)
Psychological outcomesofdifferent treatment policies inwomen with early breast canceroutside aclinical trial (1990) (0)
Historical and cultural determinants in the evolution of adjuvant endocrine therapy: a tale of two hemispheres, separated by a common language. (2012) (0)
Informed consent - Numbers inform the debate (Letter) (1998) (0)
The world overview at 10 years: what did we learn about the results of chemotherapy? (1993) (0)
Inherent Bias? Patients Who Use the Internet to Find Information on CAM (2014) (0)
The Psion of times (computing breast cancer risk in clinic) (1997) (0)
Breast cancer in the elderly (2010) (0)
Axillary nodes dissection in breast cancer. (1992) (0)
Pluripotential cells in the bone marrow (2000) (0)
The potentiating effect of x-irradiation on the induction of experimental tumours in mice. (1971) (0)
Nares und die Nasal Mastocytosis as Differential-Diagnosis of Allergic Rhinitis (1989) (0)
ATAC trial did not report interim results (2003) (0)
Effect of population-based screening on breast cancer mortality (2012) (0)
Breast cancer--a continuing enigma. (1972) (0)
American andEuropean recommendations forscreening mammography inyounger women:acultural divide? (1993) (0)
Summary of presentations at the 4th Consensus Conference of the European Society of Mastology The axillary lymph nodes in breast cancer (1995) (0)
Mammographic screening for breast cancer (Letter) (2003) (0)
Graft viability in orthotopic porcine cardiac transplantation. (1971) (0)
Breast cancerandpregnancy:a review (1993) (0)
malignant disease . diagnosis and treatment of The use of liposomes in the (2008) (0)
Letters Regarding the TARGIT-A Trial: The Editor's Introduction (2015) (0)
Targeted intraoperative radiotherapy (TARGIT) could reduce waiting times (2018) (0)
Status of molecular markers available for MAS and future plans (2008) (0)
The value of relative risks and absolute benefits when assessing treatment benefits for patients given tamoxifen in a randomised clinical trial (1992) (0)
Historical and Cultural Determinants in the Evolution of Adjuvant Endocrine Therapy (2012) (0)
Tamoxifen breast cancer prevention: The UK trials (1997) (0)
Familial Breast Cancer – a Personal View on the Progress of the Past 30 Years (2006) (0)
Planned subgroup analysis (2016) (0)
TARGETED INTRAOPERATIVE RADIOTHERAPY–THE TARGIT-A TRIAL UPDATE (2011) (0)
Breast cancer trials--a new initiative. (1981) (0)
Carcinoma of Breast: Current Controversies (1997) (0)
Detection of breast cancer recurrence by contrast-enhanced Doppler ultrasound: implications for breast biopsy (1998) (0)
Breast Cancer Research and Treatment (2004) (0)
Duration of tamoxifen therapy in the management of early operable breast cancer for postmenopsausal patients - results from the CRC trial after completion of trial therapy (2001) (0)
In reply [4] (2006) (0)
Response to "Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial."(Int J Radiat Oncol Biol Phys May 2009). (2010) (0)
National Institute for Health and Care Excellence draft recommendation and adoption (2016) (0)
Early experience with Puerto Rico: Effective use management of bone agents. (2016) (0)
The resource implications of sentinel node biopsy. (1999) (0)
ATAC: Early breast cancer (2004) (0)
Polychemotherapy for early breast cancer (Letter) (1998) (0)
Adjuvant use of anastrozole in breast cancer. Authors' reply (2004) (0)
INDIVIDUAL RISK ASSESSMENT RISK MANAGEMENT FOR CARCINOMA OF THE BREAST (2009) (0)
10-year analysis of the ATAC trial: wrong conclusion? Reply (2011) (0)
Is there a need for local prophylactic irradiation of good prognosis women with early breast cancer who are receiving systemic adjuvant therapy? Results from the CRC trial at 10 years (2001) (0)
Hoover died naturally ; ruled FBI for 48 years (0)
Sex steroids and malignancies (1997) (0)
Role of clinical trials in evaluation of cancer therapy. (1988) (0)
Abstracts of the 5th EUSOMA Consensus Conference Prognostic and predictive factors Held at the European Institute of Oncology, Milan, Italy, 5-6 October 1995 (1996) (0)
Use of progestogen for manufacturing of medicines (1989) (0)
Immunotherapy in treatment of breast cancer. (1974) (0)
‘There is no relevant benefit for cancer patients to use CAM’ (2002) (0)
Genetic screening may be a Pandora's box - but GPs are best placed to give support (1997) (0)
Acute andmodified rejection ofheterotopic canine cardiac allotransplants studied byserial needle biopsy (1971) (0)
La Fornarina does not have breast cancer (2004) (0)
Radiation safety of sentinel node biopsy in breast cancer (1999) (0)
Questions about anastrozole for early breast cancer. Authors' reply (2002) (0)
Ten year results of the CRC adjuvant breast trial (1992) (0)
Effect of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer (1987) (0)
Women prefer breast cancer prognosis expressed as chance of cure to 10-year survival (1998) (0)
130 Over-diagnosis and the Natural History of ‘Early’ Breast Cancer (2012) (0)
Mammographic screening in women under age 50 (2005) (0)
Implication for health care and practice (2016) (0)
The cost implications of sentinel node biopsy in breast cancer management. (1999) (0)
re: Primary tamoxifen for elderly women with breast cancer (1993) (0)
0-109. Preliminary report: the CRC adjuvant breast trial for patients under the age of fifty (1997) (0)
A regulatory model for cancer: the evidence and strategies which follow (1997) (0)
A random, double blind, parallel-group trial to evaluate the effect of "Arimidex" (anastrozole) on the pharmokinetics of tamoxifen in postmenopausal breast cancer patients (1997) (0)
In Reply to Park et al. (2016) (0)
Spiral CT and lung cancer biology (1998) (0)
MULTICENTRICITY AND RECURRENCE OF BREAST CANCER. AUTHORS' REPLIES (1997) (0)
Pro: Genetic testing should be discouraged (1998) (0)
Replay to letter by Drs Gillis and Hole (1982) (0)
Radical surgery for early breast cancer. (1981) (0)
Screening of inherited breast cancer with DNA markers. (1993) (0)
Current Issues in Breast Cancer Editorial Cancer Control (2004) (0)
Effect of pre-medication drugs on serum hormone levels in women undergoing breast surgery (1996) (0)
Breast cancer prognosis expressed as "chance of cure" is preferable to "10 year survival" (1998) (0)
Targeted Intraoperative Radiotherapy Trial for Breast Cancer: Review After First 10 Years of Clinical Application (2010) (0)
A Risk-Adapted Approach to Breast Radiation Using Targeted Intraoperative Radiotherapy (TARGIT) (2016) (0)
Conception after breast cancer: a word of comfort. (2008) (0)
Informed consent in surgical trials. (1984) (0)
MRI does not currently influence the amount of breast tissue excised in conservative breast surgery (1998) (0)
Screening for breast cancer: time for a rethink. (2012) (0)
A national randomised trial of HRT in symptomatic women with early stage breast cancer (1997) (0)
NEEDLE BIOPSY AND " BLIND " SUBCUTANEOUS MASTECTOMY FOR BREAST DISEASE (1975) (0)
0-54. Local irradiation reduces breast relapses in the presence of systemic adjuvant therapy (1997) (0)
Paradoxes and provocations in breast cancer (1998) (0)
Pre-operative detection of breast cancer multicentricity with MRI (1998) (0)
Hormone replacement therapy and the breast. Women still want to have hormone replacement therapy. (2002) (0)
There may never be a final cure for breast cancer (unless we think outside the box). (2001) (0)
Future Developments in Adjuvant and Palliative Systemic Endocrine Therapies (1996) (0)
Clinical trials in early breast cancer. 2nd Heidelberg Symposium, Heidelberg, December 14-17, 1981. (1982) (0)
Treatment of early breast cancer. (1978) (0)
Organization ofClinical Trial onNational Scale: Management ofEarlyCancer oftheBreast (1972) (0)
The use of gestodene for the preparation of medicaments (1990) (0)
Overdiagnosis of in-situ and invasive breast cancer as a result of screening (2004) (0)
HISTORICAL NOTE Breast cancer mysteries of the axillary pyramid (1998) (0)
Tamoxifen Chemoprevention and Cardiac Disease Reply (2011) (0)
Breast cancer trials—a new initiative (1981) (0)
Terminology for carcinoma-in-situ of the breast. (1996) (0)
Role of imprint cytology in sentinel node biopsy for breast cancer. (1999) (0)
Multicentricity and recurrence of breast cancer (multiple letters) [15] (1997) (0)
Recent history of Intraoperative radiotherapy for breast cancer. (2009) (0)
The Edwin Smith Papyrus : Anonymous Breasted JH (2004) (0)
CMF versus epirubicin in advanced breast cancer: Validating a new QoL tool (1992) (0)
Recommendations for research (2016) (0)
Diagnosis and management of early-stage breast cancer management of breast cancer:perspective from England. (1995) (0)
Is postoperative radiotherapy necessary in the management of early breast cancer patients who also receive adjuvant systemic treatment (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael J. Baum?

Michael J. Baum is affiliated with the following schools:

University College London

Michael J. Baum's Academic­Influence.com Rankings

Michael J. Baum's Degrees

Why Is Michael J. Baum Influential?

Michael J. Baum's Published Works

Published Works

What Schools Are Affiliated With Michael J. Baum?

Michael J. Baum's AcademicInfluence.com Rankings